Guangdong Battles China's Largest Chikungunya Outbreak as Cases Pass 10,000

Foshan at the Center of an Expanding Outbreak

More than 10,000 chikungunya cases have been reported in Guangdong province since June 2025, making this China's largest outbreak of the mosquito-borne disease. As of August 9, the outbreak is centered on Foshan and has reached at least 12 other cities in the province, with isolated cases also emerging in Hong Kong, Macau, Hunan and Taiwan.

Guangdong's response stretches from insecticide spraying and drones to hospital mosquito nets, inspections of homes and penalties for leaving standing water. Some controls recall China's COVID-19 response and have prompted debate about privacy and whether the measures match the threat.

All reported cases in the Guangdong outbreak have been mild, with no deaths or severe complications. Yet chikungunya can cause intense joint pain, and some patients elsewhere have experienced symptoms lasting months or years. The immediate task is to stop mosquitoes carrying the virus from reaching more people while protecting residents most vulnerable to serious illness.

The outbreak also exposes a weakness in a population with little immunity to a virus rarely encountered in China. Heavy rain, flooding, warmer conditions and international travel have helped create opportunities for infection to spread.

How the Outbreak Developed

Foshan's Shunde District has carried the largest share of infections. Although Guangdong's reported case total covers the period since June, the first cluster in Foshan was reported on July 9. Cases then rose rapidly through late July.

The main developments are:

• Since June 2025: Guangdong has recorded more than 10,000 cases.
• July 9: The first cluster of chikungunya fever cases was reported in Foshan.
• Late July: Confirmed cases had reached nearly 5,000, mostly in Shunde District.
• By August 9: The outbreak had spread to at least 12 other Guangdong cities, with isolated cases detected in Hong Kong, Macau, Hunan and Taiwan.

Most patients are adults aged 15 to 64, and the median age is 44. Fever, joint pain and rash commonly occur together. Nearly all patients recover within a week, although some have lingering joint pain.

Genetic analysis identified the Guangdong virus as belonging to the Central African clade of the East/Central/South African genotype, known as ECSA. A clade is a branch of the virus's family tree. The finding matches strains circulating in other global hotspots.

What Chikungunya Does to the Body

Chikungunya spreads through bites from infected Aedes mosquitoes, mainly Aedes aegypti and Aedes albopictus. It cannot spread through the air or directly from one person to another. Mosquitoes are therefore central to both its spread and the effort to contain it.

The virus was first identified in Tanzania in 1952. Its name comes from the Kimakonde language and means "that which bends up," referring to the bent posture that severe joint pain can cause.

Symptoms usually begin three to seven days after an infected mosquito bites someone. They include:

• Sudden high fever.
• Severe joint pain, particularly in the hands, wrists, ankles and feet.
• Muscle pain and headache.
• Fatigue.
• Skin rash.

Most people recover within one or two weeks. For some, joint pain makes walking or ordinary daily activities difficult. About 20% experience pain lasting months or even years. Older adults, newborns and people with chronic health conditions are of particular concern.

Deaths are rare, with an estimated mortality rate of about one in 1,000 cases. The groups at greatest risk of severe disease include newborns infected at birth, adults older than 65 and people with conditions such as heart disease or diabetes.

Guangdong's record of mild cases is encouraging, but the illness still creates a burden for people who cannot move comfortably, work or manage their usual activities while recovering.

Why Guangdong Became Vulnerable

Unusually heavy rain and flooding have created favorable breeding conditions for mosquitoes in Guangdong. Standing water provides places where mosquitoes can reproduce, making water removal a central part of the response.

Rising temperatures associated with climate change have expanded the range and activity of Aedes mosquitoes. Warmer conditions and heavier rainfall can bring chikungunya, dengue and Zika risks to places that previously experienced them less often.

International travel adds another route for the virus to move. Foshan's initial cluster was likely linked to an imported case. Once introduced, the virus encountered a population with little immunity, allowing infections to spread rapidly.

China has documented sporadic imported chikungunya cases and small outbreaks since 2008. The current outbreak is unprecedented in scale for the country, exposing gaps in preparedness for a disease that many communities have rarely faced.

Climate change, urbanization and increased travel together form the wider setting for the outbreak. Guangdong's immediate challenge is concrete: reduce mosquito breeding and prevent mosquitoes from biting infected people and then carrying the virus onward.

A Wider Global Surge

Chikungunya has caused outbreaks in Africa, South and Southeast Asia, the Americas, and islands in the Indian and Pacific Oceans. Guangdong's outbreak is part of a broader increase in infections during 2025.

The European Centre for Disease Prevention and Control has recorded more than 240,000 infections and 90 deaths across 16 countries this year. La Réunion alone has reported nearly 50,000 cases, compared with Guangdong's total of more than 10,000.

The comparison shows the difference between China's experience and that of places facing larger outbreaks. Guangdong's total is unprecedented nationally, while La Réunion's reported figure is much higher.

International movement creates opportunities for the virus to reach new places. A single infected traveler can introduce it where mosquitoes capable of spreading it are present. Millions of people travel between China and other countries each year.

The United States has recorded dozens of cases associated with travel in 2025, although it has had no local transmission since 2019. Surveillance and international cooperation are part of efforts to keep imported infections from becoming new outbreaks.

Spraying, Drones, Fish and Mosquito Predators

Guangdong authorities have mobilized a broad campaign against the mosquitoes that transmit chikungunya. Insecticides are being sprayed in streets, parks, residential areas and construction sites.

Drones are being used to identify and treat breeding sites, including rooftops and areas holding water that are difficult for workers to reach. Monitoring mosquito populations as conditions change helps authorities decide where to direct control efforts.

Biological controls add another approach. Authorities have introduced elephant mosquitoes, whose larvae prey on the larvae of species that carry disease. More than 5,000 fish that eat mosquitoes have also been released into city lakes and ponds.

Community workers are visiting homes to inspect for stagnant water. Households that fail to remove it can face fines of up to 10,000 yuan, about $1,400, and even electricity cutoffs.

The campaign combines chemical treatment, biological controls and action by residents. Each addresses a different part of the problem: killing mosquitoes, reducing their young or removing the water where they breed.

Public messages urge residents to wear long sleeves, use insect repellent and install window screens or bed nets. Nets are especially useful for babies and people unable to use repellents.

Why Patients Are Kept Under Mosquito Nets

Foshan requires patients who test positive to stay in hospital wards under mosquito nets for at least a week or until they test negative. The purpose is to prevent mosquitoes from biting infected patients and then spreading the virus to others.

Hospital restrictions have drawn comparisons with COVID-19 controls, but chikungunya's route of transmission shapes the practical goal. Keeping mosquitoes away from infected people interrupts the chain through which the disease spreads.

Some cities initially required travelers arriving from Foshan to quarantine at home for 14 days. Those requirements were dropped after confirmation that chikungunya cannot pass directly from person to person.

Pharmacies in affected areas have also been ordered to track sales of fever and pain medicines. Purchases require registration under the buyer's real name, bringing another element familiar from the pandemic response into the outbreak campaign.

The combination of hospital stays, pharmacy monitoring and inspections has made disease control a visible part of daily life. It has also brought questions about how much personal information authorities collect and how they use it.

Residents Challenge Intrusive Controls

Many residents have accepted the measures as necessary, while others have criticized their severity and intrusion into private life. Social media accounts describe inspections late at night, forced blood tests and searches of properties without consent.

One widely shared incident involved officials entering a child's bedroom at night to collect blood samples after a pharmacy reported a purchase of fever medicine. Such incidents have fueled concern about privacy and the reach of local enforcement.

Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relations, described a tension between the disease's characteristics and China's limited population immunity:

Some of the current measures are likely overkill. Chikungunya is rarely fatal, and the mosquito-borne virus can't spread through the air. But because outbreaks are rare in China, some of the measures are justified given the population has no immunity.

Authorities have defended their actions as necessary to prevent a wider epidemic. They have also responded to criticism by investigating controversial incidents and adjusting protocols.

Public cooperation remains central to removing standing water and reducing mosquito bites. Clear communication about why a measure is needed, alongside respect for privacy, is part of the challenge facing officials.

Travel Advice and Vaccine Access

The U.S. Centers for Disease Control and Prevention has issued a Level 2 travel advisory for Guangdong, urging travelers to take extra precautions. Its advice focuses on avoiding mosquito bites and recognizing symptoms after travel.

Recommended precautions include:

• Use insect repellent containing DEET or another approved ingredient.
• Wear shirts with long sleeves and long pants.
• Stay in accommodation with air conditioning or screens.
• Seek medical attention for fever, rash or joint pain after visiting an affected area.

Pregnant women are advised to avoid travel to outbreak areas because infection passed during delivery can cause severe illness in newborns. The CDC also recommends vaccination for travelers going to places with outbreaks.

Two chikungunya vaccines have been approved in the United States. IXCHIQ is a live attenuated vaccine, meaning it uses a weakened form of the virus, for adults aged 18 and older. It is not recommended for people older than 60 because of rare severe side effects.

VIMKUNYA is a vaccine using particles that resemble the virus and is approved for adolescents and adults aged 12 and older. It is preferred for pregnant women and people older than 60.

Both vaccines offer protection within about two weeks of a single dose. Neither is currently available in China, limiting their role in controlling Guangdong's outbreak. For residents, mosquito control and protection from bites remain the tools immediately available.

Treatment and the Need to Check for Dengue

No specific antiviral treatment is available for chikungunya. Care focuses on rest, fluids and relief from fever and pain.

Acetaminophen can be used for symptoms. Nonsteroidal anti-inflammatory drugs, or NSAIDs, may also be used after dengue has been ruled out, because these medicines can worsen dengue.

Chikungunya, dengue and Zika can be difficult to distinguish because the same mosquitoes spread them and their symptoms overlap. Chikungunya is more likely to cause severe, prolonged joint pain. Dengue is associated with bleeding complications, while Zika is associated with birth defects.

Hospitalization is rarely necessary for chikungunya except for vulnerable patients or people at risk of complications. Foshan's requirement for hospital stays also serves the separate public health purpose of keeping mosquitoes from biting infected patients.

People with persistent pain may face a longer recovery even after fever and other early symptoms subside. The absence of severe cases in Guangdong so far sits alongside the need to monitor older patients, newborns and people with existing illnesses.

Early Signs of Decline, With Risks Continuing

Recent figures suggest that new infections in Guangdong are beginning to decline, indicating that containment measures may be working. Hot, humid weather and the resumption of travel continue to create opportunities for further spread.

Health authorities are urging continued vigilance in China and elsewhere. Early detection, a rapid response, mosquito surveillance and cooperation across borders remain central to limiting new clusters.

Dr. Diana Rojas Alvarez of the World Health Organization warned of the possibility of a repeat of an earlier major epidemic:

History may be repeating itself, referencing the massive 2004–2005 epidemic that sickened nearly half a million worldwide. With the virus now confirmed in Taiwan and continuing its rapid spread, prevention efforts will be critical to keeping chikungunya from becoming the next major global health crisis.

Guangdong's campaign demonstrates the resources China can mobilize, from drones to biological controls and extensive monitoring. Residents' objections also show the need to balance disease prevention with individual rights and privacy.

The practical lessons are linked: find infections early, combine chemical and biological mosquito controls with community action, explain decisions plainly and share information internationally. Sustaining those efforts matters while conditions remain favorable for mosquitoes.

Key Points

• Guangdong has reported more than 10,000 chikungunya cases since June 2025, China's largest outbreak.
• Foshan is the center, with spread to at least 12 other Guangdong cities and isolated cases in Hong Kong, Macau, Hunan and Taiwan.
• All reported Guangdong cases have been mild, with no deaths or severe complications.
• The virus spreads through infected mosquitoes and can cause severe joint pain lasting months or years.
• Controls include spraying, drones, biological measures, hospital mosquito nets, inspections and penalties.
• Intrusive inspections and medicine purchase monitoring have prompted privacy concerns.
• The CDC has issued a Level 2 travel advisory. Two vaccines approved in the United States are unavailable in China.
• New infections appear to be declining, but hot, humid conditions and travel sustain the risk of further spread.